Shilpa Pharma Clears ANVISA Hurdle with Flying Colors—Unit-I Passes Brazil GMP Audit

Unknown Apr 02, 2026 900 Views

Shilpa Medicare Ltd has announced a major regulatory milestone: its wholly owned subsidiary, Shilpa Pharma Lifesciences Ltd (Unit-I) has successfully completed a Good Manufacturing Practice (GMP) inspection by ANVISA, Brazil’s national health surveillance agency. The inspection, conducted f...